Finance

Hims & Hers Shape of America report

Weight is Weighing on the Majority of Americans, Survey Finds

A new report from Hims & Hers underscores the urgency of weight loss for Americans as companies race to distribute weight loss medications.

health and fitness software market

Health and Fitness Software Market to Hit $19.1B by 2031

A new report shows the projected health and fitness software market growth is fueled by consumer interest in health and M&As.

crunch fitness

TPG Explores $1.5B+ Sale of Crunch Fitness Per Report

Private equity firm TPG is considering a potential $1.5B sale of Crunch Fitness, which could take place in 2025.

Growl boxing bag hangs on a wall

Growl Raises $4.75M for Boxing Bag That Puts a Coach in Your Living Room

French-American startup Growl is on a mission to bring the benefits of boxing fitness to the masses through virtual coaching and gamification.

men working out in a gym with dumbbells

Exerp Partners with Fintech Provider

Exerp and Ezypay have formed a strategic partnership with Ezypay to make it easier for fitness businesses to streamline payment options.

man and woman exercising at Blink fitness

Bankruptcy Court Greenlights Blink Fitness Sale to PureGym

PureGym has scored Blink Fitness locations in New York and New Jersey in a $121 million deal that will advance its North American endeavors.

exterior shot of an Anytime Fitness gym

Private Equity Sees Big Future for Anytime Fitness

Private equity money has flooded into big-box gyms recently, but the smart money could be headed to smaller-sized gyms like Anytime Fitness.

The Ladder strength training app

Ladder Levels Up with Major Investments

Ladder, the top-rated strength training app, has secured two major investments to fuel its growth and push into corporate wellness and more.

Crunch Canada

Trive Doubles Down on Crunch Canada with Second Investment

Crunch Canada, the country's master franchise, has secured a new investment from Trive Capital and 808 Capital Partners to fuel growth.

23andMe

23andMe Lays Off 40% of Staff, Dissolves Therapeutics Division

23andMe, once a biotech unicorn, is struggling to stay afloat, marred by several challenges, including the swift resignation of its board.